Inhibiteurs de la synthèse d'acides gras : Questions médicales fréquentes
Nom anglais: Fatty Acid Synthesis Inhibitors
Descriptor UI:D054872
Tree Number:D27.505.519.186.071.401
Termes MeSH sélectionnés :
Ventricular Function, Left
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs de la synthèse d'acides gras : Questions médicales les plus fréquentes",
"headline": "Inhibiteurs de la synthèse d'acides gras : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Inhibiteurs de la synthèse d'acides gras : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-23",
"dateModified": "2025-02-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Inhibiteurs de la synthèse d'acides gras"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Mécanismes moléculaires de l'action pharmacologique",
"url": "https://questionsmedicales.fr/mesh/D045504",
"about": {
"@type": "MedicalCondition",
"name": "Mécanismes moléculaires de l'action pharmacologique",
"code": {
"@type": "MedicalCode",
"code": "D045504",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.519"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs de la synthèse d'acides gras",
"alternateName": "Fatty Acid Synthesis Inhibitors",
"code": {
"@type": "MedicalCode",
"code": "D054872",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Wuyuan Zhang",
"url": "https://questionsmedicales.fr/author/Wuyuan%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "University of Chinese Academy of Sciences, Beijing, 100049, P. R. China."
}
},
{
"@type": "Person",
"name": "Anna Worthmann",
"url": "https://questionsmedicales.fr/author/Anna%20Worthmann",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany."
}
},
{
"@type": "Person",
"name": "Alexander W Fischer",
"url": "https://questionsmedicales.fr/author/Alexander%20W%20Fischer",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany."
}
},
{
"@type": "Person",
"name": "Klaus Tödter",
"url": "https://questionsmedicales.fr/author/Klaus%20T%C3%B6dter",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany."
}
},
{
"@type": "Person",
"name": "Clay F Semenkovich",
"url": "https://questionsmedicales.fr/author/Clay%20F%20Semenkovich",
"affiliation": {
"@type": "Organization",
"name": "Division of Endocrinology, Metabolism & Lipid Research, Department of Medicine, Washington University, St. Louis, MO, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Association of arterial properties with left ventricular morphology and function in the community.",
"datePublished": "2022-08-18",
"url": "https://questionsmedicales.fr/article/35983866",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/HJH.0000000000003272"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of Corticosteroids on Left Ventricular Function in Patients With Cardiac Sarcoidosis.",
"datePublished": "2022-06-11",
"url": "https://questionsmedicales.fr/article/35701237",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.amjcard.2022.04.051"
}
},
{
"@type": "ScholarlyArticle",
"name": "Predicting poor left ventricular function recovery in Peripartum cardiomyopathy.",
"datePublished": "2023-11-07",
"url": "https://questionsmedicales.fr/article/37935592",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14767058.2023.2279018"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of left ventricular systolic function in patients with iron deficiency anemia based on non-invasive left ventricular pressure-strain loops.",
"datePublished": "2024-08-17",
"url": "https://questionsmedicales.fr/article/39152411",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12938-024-01276-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Left Atrial Strain for Assessment of Left Ventricular Diastolic Function: Focus on Populations With Normal LVEF.",
"datePublished": "2023-01-11",
"url": "https://questionsmedicales.fr/article/36752445",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jcmg.2022.10.011"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Mécanismes moléculaires de l'action pharmacologique",
"item": "https://questionsmedicales.fr/mesh/D045504"
},
{
"@type": "ListItem",
"position": 5,
"name": "Inhibiteurs de la synthèse d'acides gras",
"item": "https://questionsmedicales.fr/mesh/D054872"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Inhibiteurs de la synthèse d'acides gras - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Inhibiteurs de la synthèse d'acides gras",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Inhibiteurs de la synthèse d'acides gras",
"description": "Comment diagnostiquer une dyslipidémie ?\nQuels tests pour évaluer l'effet des inhibiteurs ?\nQuels symptômes indiquent un besoin d'inhibiteurs ?\nComment évaluer le risque cardiovasculaire ?\nQuels marqueurs biologiques sont pertinents ?",
"url": "https://questionsmedicales.fr/mesh/D054872?mesh_terms=Ventricular+Function,+Left&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Inhibiteurs de la synthèse d'acides gras",
"description": "Quels symptômes d'une hyperlipidémie ?\nComment reconnaître une résistance à l'insuline ?\nQuels signes d'une maladie métabolique ?\nQuels symptômes d'une maladie cardiaque ?\nQuels symptômes d'une stéatose hépatique ?",
"url": "https://questionsmedicales.fr/mesh/D054872?mesh_terms=Ventricular+Function,+Left&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Inhibiteurs de la synthèse d'acides gras",
"description": "Comment prévenir l'hyperlipidémie ?\nQuels exercices sont bénéfiques ?\nComment réduire le stress pour la santé ?\nQuel rôle joue l'hydratation ?\nComment éviter la sédentarité ?",
"url": "https://questionsmedicales.fr/mesh/D054872?mesh_terms=Ventricular+Function,+Left&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Inhibiteurs de la synthèse d'acides gras",
"description": "Quels médicaments inhibent la synthèse des acides gras ?\nComment les inhibiteurs affectent-ils le métabolisme ?\nQuels sont les effets secondaires des inhibiteurs ?\nComment surveiller l'efficacité du traitement ?\nQuels changements de mode de vie sont recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D054872?mesh_terms=Ventricular+Function,+Left&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Inhibiteurs de la synthèse d'acides gras",
"description": "Quelles complications peuvent survenir ?\nComment l'hyperlipidémie affecte-t-elle le foie ?\nQuels risques pour le système cardiovasculaire ?\nQuelles sont les conséquences d'une résistance à l'insuline ?\nComment l'obésité influence-t-elle la santé ?",
"url": "https://questionsmedicales.fr/mesh/D054872?mesh_terms=Ventricular+Function,+Left&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Inhibiteurs de la synthèse d'acides gras",
"description": "Quels sont les principaux facteurs de risque ?\nQuel rôle joue l'hérédité ?\nComment l'âge affecte-t-il le risque ?\nQuel impact a le mode de vie sur la santé ?\nComment le stress influence-t-il la santé ?",
"url": "https://questionsmedicales.fr/mesh/D054872?mesh_terms=Ventricular+Function,+Left&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dyslipidémie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un bilan lipidique sanguin permet de mesurer les niveaux de lipides et de déterminer la dyslipidémie."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'effet des inhibiteurs ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fonction hépatique et des dosages lipidiques sont effectués pour évaluer l'effet."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin d'inhibiteurs ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'hypercholestérolémie ou l'obésité peuvent indiquer un besoin d'inhibiteurs."
}
},
{
"@type": "Question",
"name": "Comment évaluer le risque cardiovasculaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque cardiovasculaire est évalué par des facteurs comme l'âge, le sexe, et les antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques sont pertinents ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de triglycérides et de cholestérol LDL sont des marqueurs importants à surveiller."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une hyperlipidémie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, douleurs abdominales et éruptions cutanées xanthomateuses."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une résistance à l'insuline ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme l'obésité abdominale et des niveaux élevés de glucose peuvent indiquer une résistance."
}
},
{
"@type": "Question",
"name": "Quels signes d'une maladie métabolique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une prise de poids inexpliquée, fatigue chronique et hypertension."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une maladie cardiaque ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure douleur thoracique, essoufflement et palpitations."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une stéatose hépatique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, douleur dans le quadrant supérieur droit et jaunisse."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hyperlipidémie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine, riche en fibres et pauvre en graisses saturées, aide à prévenir l'hyperlipidémie."
}
},
{
"@type": "Question",
"name": "Quels exercices sont bénéfiques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des exercices aérobiques comme la marche, la course ou le vélo sont bénéfiques pour la santé cardiaque."
}
},
{
"@type": "Question",
"name": "Comment réduire le stress pour la santé ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques de gestion du stress comme la méditation et le yoga peuvent améliorer la santé globale."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'hydratation ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hydratation est essentielle pour le métabolisme et la santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Comment éviter la sédentarité ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Intégrer des pauses actives et des activités physiques régulières dans la routine quotidienne aide."
}
},
{
"@type": "Question",
"name": "Quels médicaments inhibent la synthèse des acides gras ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme l'acide acétylsalicylique et les statines inhibent la synthèse des acides gras."
}
},
{
"@type": "Question",
"name": "Comment les inhibiteurs affectent-ils le métabolisme ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils réduisent la production d'acides gras, ce qui diminue les niveaux de lipides dans le sang."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des inhibiteurs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des troubles gastro-intestinaux et des douleurs musculaires."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'efficacité du traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des bilans lipidique et hépatique réguliers permettent de surveiller l'efficacité du traitement."
}
},
{
"@type": "Question",
"name": "Quels changements de mode de vie sont recommandés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et l'exercice régulier sont recommandés en complément des médicaments."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme l'athérosclérose et les maladies cardiaques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment l'hyperlipidémie affecte-t-elle le foie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hyperlipidémie peut entraîner une stéatose hépatique, affectant la fonction hépatique."
}
},
{
"@type": "Question",
"name": "Quels risques pour le système cardiovasculaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un excès d'acides gras peut augmenter le risque de maladies cardiovasculaires et d'accidents vasculaires cérébraux."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une résistance à l'insuline ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La résistance à l'insuline peut mener au diabète de type 2 et à d'autres complications métaboliques."
}
},
{
"@type": "Question",
"name": "Comment l'obésité influence-t-elle la santé ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité augmente le risque de maladies métaboliques, cardiovasculaires et de certains cancers."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'obésité, le tabagisme, une alimentation riche en graisses et le manque d'exercice."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'hérédité ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hérédité peut influencer le métabolisme lipidique et le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Comment l'âge affecte-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque de dyslipidémie et de maladies cardiovasculaires augmente avec l'âge."
}
},
{
"@type": "Question",
"name": "Quel impact a le mode de vie sur la santé ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sédentaire et une mauvaise alimentation augmentent le risque de maladies métaboliques."
}
},
{
"@type": "Question",
"name": "Comment le stress influence-t-il la santé ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut contribuer à l'obésité et à des troubles métaboliques, augmentant les risques."
}
}
]
}
]
}
Arterial structural and functional remodeling is recognized as a key determinant of incident heart failure, although the contribution of arterial properties on left ventricular (LV) remodeling is not ...
The study cohort consisted of 539 participants without overt cardiac disease who underwent extensive cardiovascular examination. Aortic root diameter was measured by two-dimensional echocardiography a...
Aortic root diameter and ePWV were correlated with LV mass index and LVGLS, while only ePWV was related to E / e' ratio. In multivariable analysis, aortic root diameter and ePWV were significantly rel...
Aortic root size and ePWV were independently associated with unfavorable LV remodeling in individuals free of cardiac disease, which might provide useful information into the pathogenesis-linking arte...
Cardiac sarcoidosis (CS) is an important cause of cardiomyopathy. The trajectory of left ventricular ejection fraction (LVEF) in patients with CS undergoing treatment remains unclear. Patients with CS...
Peripartum cardiomyopathy (PPCM) is a rare type of cardiomyopathy that manifests as acute heart failure associated with pregnancy. Delays in early identification result in poor recovery of left ventri...
All baseline and clinical parameters were prospectively collected from a cohort of patients with PPCM admitted to Dr. Hasan Sadikin General Hospital in Bandung, Indonesia between January 2014 and Dece...
This prospective cohort study included 113 patients with PPCM (84 recovered and 29 non-recovered patients). Significant mitral regurgitation (MR), left ventricular ejection fraction (LVEF) <30%, left ...
PPCM recovery score is a convenient scoring system based on clinical and echocardiography assessment that may assist in distinguishing which patients are more likely to develop poor LV function recove...
Iron deficiency anemia (IDA) is a common health problem worldwide. The objective of this study was to noninvasively and quantitatively evaluate early changes in left ventricular systolic function in p...
Sixty-two patients with IDA were selected and divided into two groups based on hemoglobin (Hb) concentration: Group B with Hb > 9 g/dL and group C with 6 g/dL < Hb < 9 g/dL. Thirty-three healthy indiv...
Compared to group A, GWI and GCW were reduced in group B (both P < 0.01). Compared with groups B and A, GLS, GWI, GCW and GWE, and E/A were all diminished, and GWW, LVEDV, LVESV, and E/mean e' were al...
LV-PSL allows noninvasive quantitative assessment of early impaired LV systolic function in IDA patients with preserved LV ejection fraction, and GWI has high sensitivity and specificity compared with...
Left atrial (LA) strain has emerged as a useful parameter for the assessment of left ventricular (LV) diastolic function and the estimation of LV filling pressures. Some have advocated using LA strain...
Spirometric abnormalities have been related to incident heart failure in general population, who generally have preserved left ventricular ejection fraction (LVEF). We aimed to investigate the associa...
Subjects presenting with exertional dyspnoea and received spirometry and echocardiography were eligible for this study. Forced vital capacity (FVC) and forced expiratory volume in the first second (FE...
Among a total of 8669 participants (65.8 ± 16.3 years, 56% men), 3739 (43.1%), 829 (9.6%), 3050 (35.2%) and 1051 (12.1%) had normal, obstructive, restrictive and mixed spirometry pattern, respectively...
The restrictive spirometry pattern or the declined FVC was associated with left ventricular diastolic dysfunction, which aggravated the long-term mortality in the ambulatory dyspnoeic subjects....
Coronary microvascular dysfunction (CMD) has been proposed as an important pathophysiological mechanism in Takotsubo syndrome (TTS). Our aims were (i) to evaluate and compare levels of CMD in patients...
We conducted a prospective study of 27 female TTS patients and an equally sized, age- and gender-matched, cohort of INOCA patients. Coronary microvascular function was quantified invasively using the ...
Coronary microvascular dysfunction is common in patients with TTS and more frequent than in patients with INOCA. CMD in TTS is more severe in the apical compared with the midventricular phenotype of t...
The relationship between left ventricle (LV), extracellular matrix remodeling and fibrosis-linked amphiregulin (ARG) in cirrhotic cardiomyopathy (CCM) is unknown. The aim of the study was to investiga...
Significant left-to-right shunt across a ventricular septal defect (VSD) may lead to left ventricle (LV) volume overload and dilation. The acute loss of LV preload after repair of VSD may contribute t...
To explore left ventricular structural/functional abnormalities in preeclampsia patients by using multimodal echocardiography and to analyze the cardiac impact in preeclampsia subtypes....
A total of 103 individuals, including 64 preeclampsia patients and 39 healthy pregnant women were recruited for this study from 2019 to 2021. There were 34 patients with preeclampsia with severe featu...
EO-SPE patients showed decreased left ventricular ejection fractions, peak longitudinal systolic strain at apical four-chambers, peak circumferential, and radial systolic strain at the apical and mitr...
EO-SPE patients were characterized by left ventricular injury and systolic function reduced. LO-SPE patients were characterized by left ventricular hypertrophy and reduced diastolic function. Multimod...